Stroke drug works even hours later in major trial
NCT ID NCT05752916
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study tested whether a clot-dissolving medicine called rhTNK-tPA could help people having a stroke when given between 4.5 and 24 hours after symptoms started. It included 570 adults with a stroke that was not caused by a large blocked artery. The goal was to see if more patients could recover with little or no disability 90 days later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xuanwu Hospital, Capital Medical University
Beijing, China
Conditions
Explore the condition pages connected to this study.